Symposium 3 Perspective on Targeted Molecular Therapy for Hematological Malignancy in Childhood

[SY3-5] Testing novel and targeted therapies in children, adolescents and young adults with ALL

Stephen P. Hunger (Children's Hospital of Philadelphia, Division of Pediatric Oncology, United States of America)

Dr. Hunger received his undergraduate degree in Biology from MIT and his MD from The University of Connecticut School of Medicine. He completed Pediatrics residency at Johns Hopkins Hospital and Pediatric Hematology Oncology fellowship and post-doctoral research at Stanford University.He has held previous faculty positions at the University of Colorado and Children’s Hospital Colorado (Chief of Pediatric Hematology/Oncology/BMT 2007-14) and the University of Florida (Chief of Pediatric Hematology/Oncology, 2001-07).Since 2014, Dr. Hunger has been the Chief of the Division of Oncology, the Director of the Center for Childhood Cancer Research and the Jeffrey E. Perelman Distinguished Chair in the Department of Pediatrics, Children's Hospital of Philadelphia, and a Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. He also serves as Associate Director for Pediatric Research of the University of Pennsylvania’s Abramson Cancer Center.Dr. Hunger specializes in research and treatment on children, adolescents and young adults with ALL. He has authored more than 280 peer-reviewed manuscripts. He was the Vice-Chairman (2002-2007) and Chairman (2008-2015) of the COG ALL Committee.Dr. Hunger is currently the Chairman of the Scientific Committee of SIOP and also has a major interest in global oncology, with a focus on improving cure rates for children with ALL in low and middle income countries.